Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Biotherapy demonstrates activity relevant to multiple sclerosis

June 20, 2012

First prenatal replacement therapy presented for rare form of dystonia

June 20, 2012

Promising first-in-human daratumumab results presented at recent meetings

June 19, 2012

Ongoing congress features data from first PD trial assessing exenatide efficacy/safety/tolerability

June 19, 2012

ChemoCentryx compound shows efficacy in diabetic nephropathy model

June 19, 2012

RDX-5791 studied for effects on sodium excretion in healthy volunteers

June 19, 2012

Novel PPAR-gamma agonist tested in polycystic kidney disease model

June 19, 2012

U.S. study links SNPs to aggressive prostate cancer and associated mortality

June 19, 2012

First clinical data disclosed on Bristol-Myers Squibb drug for cancer

June 18, 2012

Phase II study tests iron chelator in adults with transfusional iron overload

June 18, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...